
Sign up to save your podcasts
Or


CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP
By American College of Chest Physicians4.2
6262 ratings
CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP

1,872 Listeners

320 Listeners

500 Listeners

36 Listeners

7 Listeners

37 Listeners

3,376 Listeners

1,150 Listeners

515 Listeners

369 Listeners

260 Listeners

431 Listeners

372 Listeners

57 Listeners

272 Listeners